Year |
Citation |
Score |
2022 |
Miller PG, Sathappa M, Moroco JA, Jiang W, Qian Y, Iqbal S, Guo Q, Giacomelli AO, Shaw S, Vernier C, Bajrami B, Yang X, Raffier C, Sperling AS, Gibson CJ, et al. Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state. Nature Communications. 13: 3778. PMID 35773251 DOI: 10.1038/s41467-022-30463-9 |
0.428 |
|
2019 |
Shaw S, White JD. Asymmetric Catalysis Using Chiral Salen-Metal Complexes: Recent Advances. Chemical Reviews. PMID 31184109 DOI: 10.1021/Acs.Chemrev.9B00074 |
0.382 |
|
2019 |
Lee T, Christov PP, Shaw S, Tarr JC, Zhao B, Veerasamy N, Jeon KO, Mills JJ, Bian Z, Sensintaffar JL, Arnold AL, Fogarty SA, Perry E, Ramsey HE, Cook R, et al. Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer. Journal of Medicinal Chemistry. PMID 30929420 DOI: 10.2210/Pdb6Ne5/Pdb |
0.532 |
|
2018 |
Radke JB, Carey KL, Shaw S, Metkar S, Mulrooney C, Gale JP, Bittker JA, Hilgraf R, Comer E, Schreiber SL, Virgin HW, Perez JR, Sibley LD. High throughput screen identifies IFN-γ-dependent inhibitors of Toxoplasma gondii growth. Acs Infectious Diseases. PMID 30058798 DOI: 10.1021/Acsinfecdis.8B00135 |
0.53 |
|
2018 |
Shaw S, Bian Z, Zhao B, Tarr JC, Veerasamy N, Jeon K, Belmar J, Arnold AL, Fogarty SA, Perry E, Sensintaffar JL, Camper DV, Rossanese OW, Lee T, Olejniczak ET, et al. Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors Using Structure-Based Design. Journal of Medicinal Chemistry. PMID 29323899 DOI: 10.1021/Acs.Jmedchem.7B01155 |
0.534 |
|
2016 |
Lee T, Bian Z, Zhao B, Hogdal LJ, Sensintaffar JL, Goodwin CM, Belmar J, Shaw S, Tarr JC, Veerasamy N, Matulis SM, Koss B, Fischer MA, Arnold AL, Camper DV, et al. Discovery and Biological Characterization of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors. Febs Letters. PMID 27878989 DOI: 10.1002/1873-3468.12497 |
0.52 |
|
2016 |
Shaw S, White JD. cis-2,5-Diaminobicyclo[2.2.2]octane, a New Chiral Scaffold for Asymmetric Catalysis. Accounts of Chemical Research. PMID 27505459 DOI: 10.1021/acs.accounts.6b00286 |
0.42 |
|
2016 |
Pelz NF, Bian Z, Zhao B, Shaw S, Tarr JC, Belmar J, Gregg C, Camper DV, Goodwin CM, Arnold AL, Sensintaffar JL, Friberg A, Rossanese OW, Lee T, Olejniczak ET, et al. Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods. Journal of Medicinal Chemistry. PMID 26878343 DOI: 10.1021/Acs.Jmedchem.5B01660 |
0.53 |
|
2015 |
Shaw S, White JD. Regioselective and Enantioselective Addition of Sulfur Nucleophiles to Acyclic α,β,γ,δ-Unsaturated Dienones Catalyzed by an Iron(III)-Salen Complex. Organic Letters. 17: 4564-7. PMID 26356405 DOI: 10.1021/acs.orglett.5b02280 |
0.356 |
|
2015 |
Burke JP, Bian Z, Shaw S, Zhao B, Goodwin CM, Belmar J, Browning CF, Vigil D, Friberg A, Camper DV, Rossanese OW, Lee T, Olejniczak ET, Fesik SW. Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design. Journal of Medicinal Chemistry. 58: 3794-805. PMID 25844895 DOI: 10.1021/Jm501984F |
0.54 |
|
2014 |
Shaw S, White JD. A new iron(III)-salen catalyst for enantioselective Conia-ene carbocyclization. Journal of the American Chemical Society. 136: 13578-81. PMID 25213211 DOI: 10.1021/ja507853f |
0.38 |
|
2014 |
White JD, Shaw S. A new cobalt-salen catalyst for asymmetric cyclopropanation. Synthesis of the serotonin-norepinephrine repuptake inhibitor (+)-synosutine Organic Letters. 16: 3880-3883. PMID 25020111 DOI: 10.1021/ol501549x |
0.403 |
|
2012 |
White JD, Shaw S. A new catalyst for the asymmetric Henry reaction: synthesis of β-nitroethanols in high enantiomeric excess. Organic Letters. 14: 6270-3. PMID 23194499 DOI: 10.1021/ol3030023 |
0.401 |
|
2011 |
White JD, Shaw S. cis-2,5-Diaminobicyclo[2.2.2]octane, a new scaffold for asymmetric catalysis via salen-metal complexes. Organic Letters. 13: 2488-91. PMID 21462988 DOI: 10.1021/ol2007378 |
0.39 |
|
Show low-probability matches. |